Financiën Thermo Fisher Scientific, Inc.

Aandelen

TMO

US8835561023

Geavanceerde medische apparatuur & technologie

Beurs gesloten - Nyse Andere beurzen 22:00:02 22-01-2026			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
639,45 ^USD	+0,50%		+2,37%	+10,35%

20/01	THERMO FISHER SCIENTIFIC, INC. : Goldman Sachs herhaalt koopadvies	ZM
15/01	Farmasector verdubbelt inzet op AI in de hoop kosten en doorlooptijden drastisch te verlagen	RE

Voorlopige winst- en verliesrekening: Thermo Fisher Scientific, Inc.

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Omzet ¹	32.218	39.211	44.915	42.857	42.879	44.276	46.584	49.112
Variatie	-	21,71%	14,55%	-4,58%	0,05%	3,26%	5,21%	5,43%
EBITDA ¹	10.214	12.969	11.971	10.878	10.863	11.190	12.058	12.984
Variatie	-	26,97%	-7,7%	-9,13%	-0,14%	3,01%	7,76%	7,68%
Bedrijfsresultaat (EBIT) ¹	9.556	12.138	10.985	9.810	9.707	10.084	10.848	11.702
Variatie	-	27,02%	-9,5%	-10,7%	-1,05%	3,88%	7,58%	7,87%
Betaalde rente ¹	-553	-536	-726	-1.375	-1.390	-1.398	-1.317	-1.237
Resultaat voor belastingen (EBT) ¹	7.225	8.841	7.835	6.298	7.037	7.397	8.200	9.181
Variatie	-	22,37%	-11,38%	-19,62%	11,73%	5,11%	10,86%	11,96%
Nettowinst (verlies) ¹	6.375	7.725	6.950	5.995	6.335	6.717	7.387	8.250
Variatie	-	21,18%	-10,03%	-13,74%	5,67%	6,04%	9,97%	11,68%
Datum van publicatie	1/02/21	2/02/22	1/02/23	31/01/24	30/01/25	-	-	-

¹USD in Miljoen

Geschatte gegevens

Fiscaal tijdperk: december	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3
Omzet ¹	10.550	9.906	9.273	9.330	10.702	11.818	10.970	10.677	11.450	10.710	10.687	10.574	10.886	10.345	10.541	10.598	11.395	10.364	10.855	11.122	11.882	11.018	11.484	11.613	12.433	11.667	12.112	12.256
Variatie	-	-6,1%	-6,39%	0,61%	14,71%	10,43%	-7,18%	-2,67%	7,24%	-6,46%	-0,21%	-1,06%	2,95%	-4,97%	1,89%	0,54%	7,52%	-9,05%	4,74%	2,46%	6,84%	-7,28%	4,23%	1,12%	7,07%	-6,16%	3,81%	1,19%
EBITDA ¹	3.703	3.708	2.900	2.983	3.378	3.700	2.841	2.614	2.816	2.583	2.640	2.829	2.826	2.564	2.623	2.653	3.023	2.546	2.631	2.814	3.126	2.754	2.878	3.008	3.320	2.918	3.076	3.229
Variatie	-	0,14%	-21,79%	2,86%	13,24%	9,53%	-23,22%	-7,99%	7,73%	-8,27%	2,21%	7,16%	-0,11%	-9,27%	2,3%	1,14%	13,95%	-15,78%	3,34%	6,96%	11,07%	-11,9%	4,53%	4,51%	10,38%	-12,11%	5,4%	4,98%
Bedrijfsresultaat (EBIT) ¹	3.512	3.510	2.689	2.778	3.161	3.450	2.605	2.370	2.560	2.330	2.370	2.560	2.550	2.278	2.347	2.362	2.720	2.269	2.375	2.587	2.861	2.483	2.601	2.730	3.016	2.669	2.826	2.939
Variatie	-	-0,06%	-23,39%	3,31%	13,79%	9,14%	-24,49%	-9,02%	8,02%	-8,98%	1,72%	8,02%	-0,39%	-10,67%	3,03%	0,64%	15,16%	-16,58%	4,67%	8,93%	10,59%	-13,21%	4,76%	4,95%	10,47%	-11,49%	5,86%	4,01%
Charge d'intérêts ¹	-146	-125	-122	-128	-161	-136	-148	-173	-269	-300	-326	-359	-390	-363	-354	-356	-316	-303	-404	-347	-355,5	-348,7	-343,7	-336,3	-330	-289	-286	-284
Resultaat voor belastingen (EBT) ¹	-	-	2.047	2.173	1.862	2.540	1.917	1.601	1.777	1.363	1.430	1.765	1.740	1.589	1.765	1.742	1.941	1.620	1.709	1.826	2.260	1.643	1.767	1.885	2.276	1.813	2.033	2.161
Variatie	-	-	-	6,16%	-14,31%	36,41%	-24,53%	-16,48%	10,99%	-23,3%	4,92%	23,43%	-1,42%	-8,68%	11,08%	-1,3%	11,42%	-16,54%	5,49%	6,85%	23,74%	-27,28%	7,55%	6,68%	20,74%	-20,34%	12,13%	6,3%
Nettowinst (verlies) ¹	2.498	2.337	1.828	1.902	1.658	2.215	1.664	1.495	1.576	1.289	1.361	1.715	1.630	1.328	1.548	1.630	1.830	1.507	1.617	1.616	2.026	1.580	1.680	1.767	2.093	1.591	1.787	1.901
Variatie	-	-6,45%	-21,78%	4,05%	-12,83%	33,59%	-24,88%	-10,16%	5,42%	-18,21%	5,59%	26,01%	-4,96%	-18,53%	16,57%	5,3%	12,27%	-17,65%	7,3%	-0,06%	25,36%	-22,01%	6,33%	5,18%	18,47%	-23,99%	12,32%	6,38%
Datum van publicatie	1/02/21	29/04/21	28/07/21	27/10/21	2/02/22	28/04/22	28/07/22	26/10/22	1/02/23	26/04/23	26/07/23	25/10/23	31/01/24	24/04/24	24/07/24	23/10/24	30/01/25	23/04/25	23/07/25	22/10/25	-	-	-	-	-	-	-	-

¹USD in Miljoen

Geschatte gegevens

Balansprognose: Thermo Fisher Scientific, Inc.

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Nettoschuld ¹	11.410	30.393	25.964	26.840	27.266	28.286	23.962	18.970
Variatie	-	166,37%	-14,57%	3,37%	1,59%	3,74%	-15,29%	-20,83%
Datum van publicatie	1/02/21	2/02/22	1/02/23	31/01/24	30/01/25	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte kasstroom: Thermo Fisher Scientific, Inc.

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	1.474	2.523	2.243	1.479	1.400	1.527	1.613	1.685
Variatie	-	71,17%	-11,1%	-34,06%	-5,34%	9,07%	5,64%	4,45%
Vrije kasstroom (FCF) ¹	6.815	7.020	6.935	6.927	7.324	6.609	8.442	9.150
Variatie	-	3,01%	-1,21%	-0,12%	5,73%	-9,76%	27,73%	8,39%
Datum van publicatie	1/02/21	2/02/22	1/02/23	31/01/24	30/01/25	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte financiële ratio's: Thermo Fisher Scientific, Inc.

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Winstgevendheid
EBITDA-marge (%)	31,7%	33,07%	26,65%	25,38%	25,33%	25,27%	25,89%	26,44%
EBIT-marge (%)	29,66%	30,96%	24,46%	22,89%	22,64%	22,77%	23,29%	23,83%
EBT-marge (%)	22,43%	22,55%	17,44%	14,7%	16,41%	16,71%	17,6%	18,69%
Nettomarge (%)	19,79%	19,7%	15,47%	13,99%	14,77%	15,17%	15,86%	16,8%
FCF-marge (%)	21,15%	17,9%	15,44%	16,16%	17,08%	14,93%	18,12%	18,63%
Vrije kasstroom/nettoresultaat (%)	106,9%	90,87%	99,78%	115,55%	115,61%	98,39%	114,28%	110,91%
Winstgevendheid
ROA	12,26%	9,43%	9,52%	8,54%	8,55%	8,04%	8,5%	8,98%
ROE	24,34%	26,52%	21,61%	18,43%	17,4%	17,14%	16,83%	16,89%
Financiële gezondheid
Hefboom (schuld/ebitda)	1,12x	2,34x	2,17x	2,47x	2,51x	2,53x	1,99x	1,46x
Schuld/vrije kasstroom	1,67x	4,33x	3,74x	3,87x	3,72x	4,28x	2,84x	2,07x
Kapitaalintensiteit
Kapitaaluitgaven/omzet (%)	4,58%	6,43%	4,99%	3,45%	3,27%	3,45%	3,46%	3,43%
CAPEX / EBITDA (%)	14,43%	19,45%	18,74%	13,6%	12,89%	13,65%	13,38%	12,98%
CAPEX / FCF (%)	21,63%	35,94%	32,34%	21,35%	19,12%	23,1%	19,11%	18,41%
Bestanddelen per aandeel
Kasstroom per aandeel ¹	20,77	24,04	23,23	21,66	22,63	21,66	26,11	29,99
Variatie	-	15,71%	-3,35%	-6,75%	4,45%	-4,3%	20,56%	14,87%
Dividend per aandeel ¹	0,88	1,04	1,2	1,4	1,56	1,658	1,719	1,805
Variatie	-	18,18%	15,38%	16,67%	11,43%	6,26%	3,68%	5,02%
Nettoactief per aandeel ¹	86,48	103,4	112,6	120,9	130,2	138,8	151,5	166,8
Variatie	-	19,58%	8,89%	7,33%	7,73%	6,58%	9,14%	10,12%
WPA ¹	15,96	19,46	17,63	15,45	16,53	17,84	19,8	22,61
Variatie	-	21,93%	-9,4%	-12,37%	6,99%	7,93%	11,01%	14,18%
Aantal aandelen (in duizend)	396.335	394.048	394.048	386.372	382.500	375.708	375.708	375.708
Datum van publicatie	1/02/21	2/02/22	1/02/23	31/01/24	30/01/25	-	-	-